Page last updated: 2024-09-03

4-hydroxy-25-desoxyneorollinicin and fura-2

4-hydroxy-25-desoxyneorollinicin has been researched along with fura-2 in 1 studies

Compound Research Comparison

Studies
(4-hydroxy-25-desoxyneorollinicin)
Trials
(4-hydroxy-25-desoxyneorollinicin)
Recent Studies (post-2010)
(4-hydroxy-25-desoxyneorollinicin)
Studies
(fura-2)
Trials
(fura-2)
Recent Studies (post-2010) (fura-2)
62074,36212291

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fu, LW; Huang, HB; Liang, YJ; Pan, QC1

Other Studies

1 other study(ies) available for 4-hydroxy-25-desoxyneorollinicin and fura-2

ArticleYear
Circumvention of tumor multidrug resistance by a new annonaceous acetogenin: atemoyacin-B.
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1999, Volume: 20, Issue:5

    Topics: 4-Butyrolactone; Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fatty Alcohols; Fura-2; Furans; Humans; KB Cells; Tumor Cells, Cultured

1999